Dr. Philippe Saxe
Rheumatology
Florida, United States
About Dr. Saxe
Dr. Saxe is an Rheumatology Specialist in Delray Beach, Florida. He graduated from University Of Miami, Lm Miller School Of Medicine in 1985. Dr. Saxe accepts Medicare approved amount as full payment.
The medical group (Arthritis ) Dr. Saxe works with accepts Medicare approved amount as full payment.
Full Name
Philippe Saxe
Specialty
Rheumatology
Internal Medicine
Internal Medicine
School
University Of Miami, Lm Miller School Of Medicine
Graduated class of
1985
Locations
NPI
1336240076
PAC ID
2147483647
Clinician Enrollment ID
I20101122000551
Cities
1
Number of cities where Dr. Saxe has officesOffices
1
Number of officesHospitals
0
Number of hospitalsOffice Locations
DELRAY BEACH Office
Phone: (561) 495-0600
5130 Linton Blvd
F1
Delray Beach, FL - 33484-6595
Doctors and Clinicians Utilization Data
Specialty | HCPCS code | Code description | Service Count | Beneficiary count |
---|---|---|---|---|
Rheumatology | 36415 | Insertion of needle into vein for collection of blood sample | 1181 | 600 |
Rheumatology | 73030 | X-ray of shoulder, minimum of 2 views | 89 | 76 |
Rheumatology | 73562 | X-ray of knee, 3 views | 83 | 72 |
Rheumatology | 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | 37 | 30 |
Rheumatology | 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 23 | 23 |
Rheumatology | 96413 | Infusion of chemotherapy into a vein up to 1 hour | 295 | 82 |
Rheumatology | J0897 | Injection, denosumab, 1 mg | 18722 | 238 |
Rheumatology | J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 6647 | 487 |
MIPS Scoring
Merit-based Incentive Payment System (MIPS) Overall Clinician PerformanceQuality category score: 100/100
IA category score 40/40
MIPS Final Score without CPB: 100/100
MIPS Final Score: 100/100
Questions & Answers
Help others like you find out more about . Do you know the answers to any of these questions? Contribute now and help others like you.
0 Responses